International Clinical Trial: Patients With a Single, Small (2 cm or Less) Cancer Nodule in the Thyroid Gland Will be Offered Active Surveillance Initially for 5 Years. In Case of Cancer Growth or Changes in Ultrasonographic Appearance, Further Treatment Will be Offered

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822217) titled 'Patients With a Single, Small (2 cm or Less) Cancer Nodule in the Thyroid Gland Will be Offered Active Surveillance Initially for 5 Years. In Case of Cancer Growth or Changes in Ultrasonographic Appearance, Further Treatment Will be Offered' on Sept. 10.

Study Type: Observational

Primary Sponsor: University of Aarhus

Condition: Thyroid Cancer Active Surveillance

Recruitment Status: Not recruiting

Date of First Enrollment: March 1, 2026

Target Sample Size: 90

Countries of Recruitment: Denmark

To know more, visit https://clinicaltrials.gov/study/NCT07822217

Disclaimer: Curated by HT Syndication....